Aug 2026· Journal of Leukocyte Biology· Vol 118· 0 citations
Medicine
TL;DR
These findings identify NF-Y as a transcriptional safeguard of myeloid cell survival during inflammatory stress, thereby shaping disease progression and outcomes in vascular disease.
Abstract
Myeloid cells orchestrate vascular inflammation through transcriptional programs that control their maturation, effector function, and survival. While lineage-determining transcription factors establish myeloid identity, our understanding of the transcriptional regulation of myeloid cell behavior in chronic inflammatory contexts remains limited. Nuclear factor-Y (NF-Y) is a trimeric CCAAT-binding transcription factor that regulates cell proliferation and differentiation and is essential for maintaining stem and progenitor cell fitness. Here, we investigate NF-Y activity in myeloid cell function and survival using integrated single-cell transcriptomics and myeloid-specific deletion of the NF-YA subunit. At RNA level, NF-Y subunit transcripts were detected across myeloid compartments, with NF-YA enriched in proliferative macrophages and immature neutrophils. In mouse atherosclerotic lesions, low NF-YA levels were associated with macrophages exhibiting lipid-handling and phagocytic signatures and with neutrophils displaying a proinflammatory phenotype. NF-Y deficiency impaired neutrophil adhesion and rolling, increased their susceptibility to apoptosis, and promoted activation and lipid accumulation in macrophages. In vivo, myeloid NF-YA deficiency reduced circulating neutrophil counts, increased macrophage and neutrophil apoptosis during acute inflammation, expanded necrotic cores, leading to larger and more unstable atherosclerotic lesions, and aggravated both atherosclerosis and injury-induced neointimal thickening. These findings identify NF-Y as a transcriptional safeguard of myeloid cell survival during inflammatory stress, thereby shaping disease progression and outcomes in vascular disease.
Resolution of inflammation is mediated in part by agonists that engage immune cells to dampen inflammatory signaling, promote phagocytic functions, and facilitate tissue repair. G-protein coupled receptor 18 (GPR18) has emerged as an important pro-resolving receptor that is activated by endogenous mediators including R...
Hebe Agustina Mena, Andreas Patsalos, Jake Altomare et al.· Proceedings of the National...· 0 citations
Findings identify cell-intrinsic C3 as a suppressor of IFN-β production in human macrophages, highlighting the importance of the cell-intrinsic complement system in fine-tuning inflammatory responses to pathogens.
Stine Kristensen, Charlotte Årseth, Maria Yurchenko et al.· bioRxiv· 0 citations
Interferon regulatory factor 4 is defined as a context-encoded intracellular mediator only when reversible, context-resolved perturbation links target engagement to a prespecified molecular programme and disease-relevant phenotype.
Hui Zhang, Fang Cao, Jing Qian et al.· Frontiers in Immunology· 0 citations
This work identifies granulocyte-macrophage colony-stimulating factor (GM-CSF) as a central regulator of pulmonary lymphocyte homeostasis and identifies alveolar macrophages as gatekeepers of adaptive immune homeostasis in the lung.
P. Arumugam, Min-Zhe Guo, C. Williams et al.· bioRxiv· 0 citations
A strategy to generate proinflammatory human myeloid cells from human marrow‐derived CD34+ hematopoietic stem and progenitor cells with potential clinical application in cancer immunotherapy is established.
Theresa Barberi, Alan D. Friedman· Molecular Oncology· 0 citations
Macrophages are highly plastic immune cells derived from bone marrow progenitors that respond dynamically to environmental cues and coordinate inflammation, debris clearance, tissue remodeling, wound repair, and regeneration. Although traditionally classified into pro-inflammatory (M1) and anti-inflammatory (M2) phenot...
Gregory R. Lum, Bria M. Gorman, Silvana A. Sidhom et al.· Frontiers in Immunology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.